Nethra Srinivasan

1PUBLICATIONS
3CO-AUTHORS
Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 28, 2024
Imatinib remains the best frontline therapy in patients with chronic myeloid leukemia: Critical analysis of the ASC4FIRST trial.

Nethra Srinivasan, Timothée Olivier, Alyson Haslam

Pageof 1